What does CUSIP 92686J106 represent in this 13F holders report?

CUSIP 92686J106 is the security identifier for VKTX - Viking Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held VKTX - Viking Therapeutics, Inc. - Common Stock in Q2 2023?

192 institutional investors reported VKTX - Viking Therapeutics, Inc. - Common Stock for Q2 2023. Use the holders table for investor-level position and value details.

Viking Therapeutics, Inc. - Common Stock (VKTX)

CUSIP: 92686J106

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock
Shares outstanding: 113,177,462
Total 13F shares: 74,791,312
Share change: +7,985,530
Total reported value: $1,212,232,718
Put/Call ratio: 47%
Price per share: $16.21
Number of holders: 192
Value change: +$127,119,937
Number of buys: 113
Number of sells: 92

Quarterly Holders Quick Answers

What is CUSIP 92686J106?
CUSIP 92686J106 identifies VKTX - Viking Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 92686J106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of VKTX - Viking Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	9.7%	10,922,748	$181,863,752	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	4.7%	5,280,944	$87,927,718	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	3.6%	4,058,639	$67,576,340	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	3.4%	3,837,996	$63,903,000	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	1.8%	2,040,278	$33,970,629	—	31 Mar 2023	13F
Boxer Capital, LLC	13F	Company	1.8%	2,000,000	$33,300,000	—	31 Mar 2023	13F
VIKING GLOBAL INVESTORS LP	13F	Company	1.7%	1,955,063	$32,551,799	—	31 Mar 2023	13F
WASATCH ADVISORS LP	13F	Company	1.5%	1,705,444	$28,395,643	—	31 Mar 2023	13F
Laurion Capital Management LP	13F	Company	1.5%	1,697,352	$28,260,911	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	1.2%	1,343,308	$22,366,078	—	31 Mar 2023	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.99%	1,125,000	$18,731,250	—	31 Mar 2023	13F
Point72 Asset Management, L.P.	13F	Company	0.97%	1,093,335	$18,204,028	—	31 Mar 2023	13F
Cormorant Asset Management, LP	13F	Company	0.93%	1,050,000	$17,483,000	—	31 Mar 2023	13F
GREAT POINT PARTNERS LLC	13F	Company	0.88%	1,000,000	$16,650,000	—	31 Mar 2023	13F
RTW INVESTMENTS, LP	13F	Company	0.88%	1,000,000	$16,650,000	—	31 Mar 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.79%	896,528	$14,927,191	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.78%	878,611	$14,628,873	—	31 Mar 2023	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.77%	871,747	$14,514,588	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.76%	863,232	$14,372,824	—	31 Mar 2023	13F
D. E. Shaw & Co., Inc.	13F	Company	0.75%	850,055	$14,153,416	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.7%	789,845	$13,150,920	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.67%	761,200	$12,674,000	—	31 Mar 2023	13F
Integral Health Asset Management, LLC	13F	Company	0.64%	727,100	$12,106,215	—	31 Mar 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.61%	695,705	$11,583,488	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.6%	673,786	$11,218,537	—	31 Mar 2023	13F
Affinity Asset Advisors, LLC	13F	Company	0.55%	622,249	$10,360,446	—	31 Mar 2023	13F
Ghost Tree Capital, LLC	13F	Company	0.53%	600,000	$9,990,000	—	31 Mar 2023	13F
683 Capital Management, LLC	13F	Company	0.51%	580,000	$9,657,000	—	31 Mar 2023	13F
CITIGROUP INC	13F	Company	0.49%	559,741	$9,319,687	—	31 Mar 2023	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.49%	556,607	$9,267,507	—	31 Mar 2023	13F
Rafferty Asset Management, LLC	13F	Company	0.48%	540,312	$8,996,195	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.47%	534,332	$8,900,842	—	31 Mar 2023	13F
GROUP ONE TRADING LLC	13F	Company	0.46%	515,952	$8,590,601	—	31 Mar 2023	13F
Nicholas Investment Partners, LP	13F	Company	0.45%	507,070	$8,442,716	—	31 Mar 2023	13F
Soleus Capital Management, L.P.	13F	Company	0.41%	460,000	$7,659,000	—	31 Mar 2023	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.35%	394,767	$6,572,871	—	31 Mar 2023	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.35%	391,136	$6,522,182	—	31 Mar 2023	13F
SILVERARC CAPITAL MANAGEMENT, LLC	13F	Company	0.34%	380,000	$6,327,000	—	31 Mar 2023	13F
Octagon Capital Advisors LP	13F	Company	0.33%	375,000	$6,243,750	—	31 Mar 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.32%	357,645	$5,954,789	—	31 Mar 2023	13F
5AM Venture Management, LLC	13F	Company	0.31%	350,000	$5,827,500	—	31 Mar 2023	13F
Lisanti Capital Growth, LLC	13F	Company	0.31%	349,470	$5,818,676	—	31 Mar 2023	13F
Informed Momentum Co LLC	13F	Company	0.3%	339,659	$5,655,322	—	31 Mar 2023	13F
LORD, ABBETT & CO. LLC	13F	Company	0.29%	333,534	$5,554,000	—	31 Mar 2023	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.29%	330,355	$5,500,410	—	31 Mar 2023	13F
MACQUARIE GROUP LTD	13F	Company	0.29%	330,100	$5,496,000	—	31 Mar 2023	13F
DAFNA Capital Management LLC	13F	Company	0.28%	319,155	$5,313,931	—	31 Mar 2023	13F
Artal Group S.A.	13F	Company	0.27%	300,000	$4,995,000	—	31 Mar 2023	13F
Monashee Investment Management LLC	13F	Company	0.27%	300,000	$4,995,000	—	31 Mar 2023	13F
SIMPLEX TRADING, LLC	13F	Company	0.26%	289,240	$4,815,000	—	31 Mar 2023	13F

Institutional Holders of Viking Therapeutics, Inc. - Common Stock (VKTX) as of Q2 2023

As of 30 Jun 2023, Viking Therapeutics, Inc. - Common Stock (VKTX) was held by 192 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 74,791,312 shares. The largest 10 holders included FMR LLC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, VIKING GLOBAL INVESTORS LP, ALLIANCEBERNSTEIN L.P., Boxer Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, and WASATCH ADVISORS LP. This page lists 192 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

183

Q2 2023 holders

192

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.